- Home
- » Tags
- » Pityriasis rubra pilaris
Top View
- Adalimumab for the Treatment of Pityriasis Rubra Pilaris: a Case Report
- Remission of Pityriasis Rubra Pilaris with IL-17A Antagonist Secukinumab
- Dead Sea Minerals
- Papulosquamous Skin Eruptions
- Diagnosis and Treatment of Pityriasis Rubra Pilaris Alexey KUBANOV1,2, Yulia GALLYAMOVA2,*
- Figurate Erythemas and Purpuras Dr
- Circumscribed Juvenile-Onset Pityriasis Rubra Pilaris with Hypoparathyroidism and Brachyonychia
- Basic Principles of Dermatology 0 Whitney A
- A Study of Pathological and Clinical Parameters of Non-Infectious, Erythematous Papulosquamous Disorders of Skin in a Tertiary Care Hospital in Central India
- Pityriasis Rubra Pilaris: an Update Review
- Table 2. Comparison of Biologic Agents: Mechanisms of Action, Indications, Dosing, and Half-Lives [3, 14, 19-28]
- REPORTS on SCIENTIFIC MEETINGS the First Topical
- Trifarotene: a Current Review and Perspectives in Dermatology
- A Histopathologic Study of Papulosquamous Lesions of Skin
- October 2019 Educational Conference
- 2 Psoriasis and Pityriasis Rubra Pilaris
- Breast Cancer Presenting As Paraneoplastic Erythroderma: an Extremely Rare Case
- An Open Label Pilot Trial of Guselkumab in the Treatment of Adults with Pityriasis Rubra Pilaris (PRP)
- Global Burden of Skin Disease As Reflected in Cochrane Database Of
- Rush University, May 2019
- COVID-19 Astrazeneca Vaccine Analysis Print
- Recent Advances in Understanding Ichthyosis Pathogenesis [Version 1; Peer Review: 2 Approved] Nareh V
- Graham-Little-Piccardi-Lassueur Syndrome
- Graham-Little-Piccardi-Lassueur Syndrome: a Case Report